Tailored Treatment for Advanced Lung Cancer?:
Links shared publicly online about this topic.
- 1,072total visits
Tailored Treatment for Advanced Lung Cancer?:
View full resource at health.msn.com
Tags: Cancer, Lung Cancer, Lung
Most Recently Shared on June 23, 2010 at 10:35 pm By:
Tailored Treatment for Advanced Lung Cancer?: http://bit.ly/9p72Cb
Clinicians to discuss best approaches for future cancer treatment at Brainlab's radiotherapy meeting
news-medical.net — “Today clinicians from around the world will gather at the 4th Brainlab European Radiotherapy User Meeting to share their best practice and experiences in treating difficult-to-treat cancers using advanced radiotherapy.” View full resource at news-medical.net
Most Recently Shared on March 17, 2012 at 10:34 am By:
Prostate Cancer: Clinicians to discuss best approaches for future cancer treatment at Brainlab's radiotherapy me... http://t.co/XHmhMBrI
Early-Stage Lung Cancer Gets New Surgical Treatment with Robot on ADVANCE for Respiratory Care and Sleep Medicine
respiratory-care-sleep-medicine.advanceweb.com — “Early-Stage Lung Cancer Gets New Surgical Treatment with Robot on ADVANCE for Respiratory Care and Sleep Medicine” View full resource at respiratory-care-sleep-medicine.advanceweb.com
Most Recently Shared on March 16, 2012 at 5:31 pm By:
Canadian thoracic surgeons use robotic surgical system to treat early-stage lung cancer http://t.co/9zdv5bM1
CME: Tailoring Treatment Plans to Improve Survival in Non-Small Lung Cancer - OncologySTAT
oncologystat.com — “Free Online Medical CME Course Credits: Tailoring Treatment Plans to Improve Survival in Non-Small Lung Cancer” View full resource at oncologystat.com
Most Recently Shared on March 15, 2012 at 3:38 pm By:
OncologySTAT Oncology and Health Site
CME Program: Tailoring Treatment Plans to Improve Survival in Non-Small Cell Lung Cancer http://t.co/1TjvHei1
Radiation therapy may not benefit many older lung cancer patients
news-medical.net — “A new study has found that many older lung cancer patients get treatments that may not help them live longer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that physicians should not routinely use radiation after surgery to treat lung cancer that is advanced but has not widely spread, at least in older patients.” View full resource at news-medical.net
Most Recently Shared on February 13, 2012 at 1:38 pm By:
Radiation therapy may not benefit many older lung cancer patients: A new study has found that many older lung ca... http://t.co/qDlZ3CbR
PORT may not prolong life in older people with NSCLC
news-medical.net — “Researchers from Mount Sinai School of Medicine have found that post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.” View full resource at news-medical.net
Most Recently Shared on February 13, 2012 at 10:39 am By:
Lung Cancer News: PORT may not prolong life in older people with NSCLC: Researchers from Mount Sinai School of M... http://t.co/8tfhIKRx
Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours
news-medical.net — “Circadian Technologies Limited announced today that it has commenced the first Phase 1 clinical trial of its fully human monoclonal antibody against VEGF-C, VGX-100, at a leading US-based cancer treatment centre.” View full resource at news-medical.net
Most Recently Shared on January 9, 2012 at 5:39 am By:
Lung Cancer News: Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours: Circadian Technologies Li... http://t.co/I2cWoG6D
LCA calls for more aggressive integration of imaging advances and biomedical research
news-medical.net — “As the War on Cancer enters its fifth decade and the number of people being diagnosed with cancer continues to rise, Lung Cancer Alliance (LCA) called for more aggressive integration of advanced imaging technology and biomedical research to improve prevention, earlier detection and treatment of cancer.” View full resource at news-medical.net
Most Recently Shared on January 6, 2012 at 8:10 am By:
Prostate Cancer: LCA calls for more aggressive integration of imaging advances and biomedical research: As the W... http://t.co/g7pmQSdg
Advances in Lung Cancer Treatment Show Incremental Benefits, but Room for Improvement Remains - The ASCO Post
ascopost.com — “Advances in Lung Cancer Treatment Show Incremental Benefits, but Room for Improvement Remains - The ASCO Post” View full resource at ascopost.com
Most Recently Shared on January 5, 2012 at 3:00 pm By:
Wafik El-Deiry MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Advances in Lung Cancer Treatment Show Incremental Benefits, but Room for Improvement Remains - The ASCO Post: http://t.co/0tbrtpJm
Gene test helps tailored treatment for cancer patients - Yahoo! News
news.yahoo.com — “From Yahoo! News: Doctors on Wednesday said they had used a wide-ranging genetic test for mutations in cancer cells to help finetune treatment for patients with lung tumours.” View full resource at news.yahoo.com
Most Recently Shared on November 9, 2011 at 8:27 am By:
Raymond DuBois Health Executive, Physician, Doctor, Internist, and Gastroenterologist
Gene test helps tailored treatment for cancer patients - http://t.co/MIt63EX3 via @YahooNews
Advances in Enteral Feeding at Penn Medicine | Clinical Briefings™ & Clinical Reports from Penn Medicine
penn-medicine-clinical-reports.blogspot.com — “The Penn Clinical Briefings offer concise reports about recent clinical developments and procedures at Penn Medicine. Written specifically for physicians, each Briefing contains a descriptive overview, a case study and referral and access information. Recent Briefing subjects have included lung cancer surgery, neuroendocrine tumor management, patellofemoral replacement surgery, treatment of lymphangioleiomyomatosis and robotic-assisted sacrocolpopexy surgery, among many others.” View full resource at penn-medicine-clinical-reports.blogspot.com
Most Recently Shared on November 7, 2011 at 3:39 pm By:
Penn Medicine Healthcare System
Clinical Briefings: Advances in Enteral Feeding at Penn Medicine http://t.co/aymNoxw8
West egfr mutation acquired resistance
slideshare.net — “Review by Dr. H. Jack West of current understanding of mechanisms behind and emerging treatment options for patients with advanced NSCLC with acquired resista” View full resource at slideshare.net
Most Recently Shared on October 22, 2011 at 8:30 pm By:
H. Jack West, MD Doctor, Internist, Health Executive, Oncologist, and Physician
My SlideShare upload on pts w/adv #LungCancer & #EGFR mut'n, then acquired resistance: mechanisms & Rx options http://t.co/eUO5YhDr
Advances in yttrium-90 radioembolization for liver cancer
news-medical.net — “Finding innovative, minimally invasive ways to treat liver cancer-and being able to tailor that treatment individually to patients-are hallmarks of interventional radiologists. Advances in yttrium-90 (Y-90) radioembolization for liver cancer, a leading cause of cancer deaths worldwide, are reported in studies in the October Journal of Vascular and Interventional Radiology.” View full resource at news-medical.net
Most Recently Shared on October 20, 2011 at 3:42 pm By:
News-Medical.Net Oncology and Health News
Oncology News: Advances in yttrium-90 radioembolization for liver cancer: Finding innovative, minimally invasive... http://t.co/TBhM8bku
Case Western study on PET imaging and lung cancer outcomes - National Cancer Institute
cancer.gov — “Advanced imaging with Positron Emission Tomography (PET) scans shows great promise in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, accord” View full resource at cancer.gov
Most Recently Shared on October 6, 2011 at 7:34 pm By:
RT @NCIMedia: Study by @UHHospitals (case western) shows PET imaging effective in predicting lung cancer outcomes http://j.mp/pnq3IG
Phase 2 Study of Selumetinib for NSCLC - MPR
empr.com — “Array BioPharma announced results from its Phase 2 study conducted by Astrazeneca of selumetinib (AZD6244/ARRY-886) in combination with docetaxel for the second-line treatment of KRAS-mutant, locally advanced or metastatic non-small cell lung cancer (NSCLC).” View full resource at empr.com
Most Recently Shared on September 30, 2011 at 3:10 pm By:
Phase 2 Study of Selumetinib for #NSCLC http://ow.ly/6JEab #oncology
Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC
news-medical.net — “Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.” View full resource at news-medical.net
Most Recently Shared on September 30, 2011 at 11:36 am By:
Lung Cancer News: Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC: Array... http://t.co/24UFaSyz
Advertisement
